Home › Therapeutic areas › Oncology › T-Cell Lymphoma
T-Cell Lymphoma (2 companies)
Companies with an active program in T-Cell Lymphoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics | Oncology | 1 | — | $203M | 6 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | $1.70B | 9 |
No companies match.